col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

110 Results       Page 1

American Society of Hematology: Blood Advances
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―11 COVID-19 mRNA Vaccination Responses in Individuals With Sickle Cell Disease: ASH RC Sickle Cell Research Network Study Alan R. Anderson, John J Strouse, Deepa Manwani, Amanda M. Brandow, Elliott P. Vichinsky, Andrew Campbell, et al. (+14)
2 [GO] 2024―Jun―17 Safety and Feasibility of Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19 Dolores Grosso, John L. Wagner, Allyson O'Connor, Kaitlyn Keck, Yanping Huang, Zi-Xuan Wang, et al. (+9)
3 [GO] 2024―Mar―24 SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow Isabelle Allaeys, Guillaume Lemaire, Mickael Leclercq, Emile Lacasse, Maude Fleury, Isabelle Dubuc, et al. (+8)
4 [GO] 2023―Sep―20 COVID-19 in patients with classic and variant hairy cell leukemia Robert J. Kreitman, Theresa Yu, Lacey James, Julie Catherine Feurtado, Holly Eager, Olena Sierra Ortiz, et al. (+8)
5 [GO] 2023―Aug―30 Even after SARS-CoV-2 Booster There is Increased COVID-19 Breakthrough Infection in Patients with Plasma Cell Disorders Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, June K Corrigan, Westyn Branch-Elliman, Paul Monach, et al. (+3)
6 [GO] 2023―Aug―08 Peripheral megakaryocytes sound the alarm in COVID-19 Eric Boilard, Kellie R. Machlus
7 [GO] 2023―Jul―05 Management and outcome of COVID-19 in CTLA-4 insufficiency Sebastian Ochoa Gonzalez, Michael S Abers, Lindsey Belle Rosen, Amy Rump, Katherine N Howe, Jay A Lieberman, et al. (+6)
8 [GO] 2023―Jun―30 Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: A meta-analysis Tanaporn Meejun, Karan Srisurapanont, Kasama Manothummetha, Achitpol Thongkam, Nuthchaya Mejun, Nipat Chuleerarux, et al. (+14)
9 [GO] 2023―Jun―13 On a collision course: SARS-CoV-2 variants and CAR T cells Jeffery J. Auletta
10 [GO] 2023―Jun―12 Intravital imaging of 3 different microvascular beds in SARS-CoV-2-infected mice Fernanda Vargas E Silva Castanheira, Rita Nguyen, Michelle Willson, Marcela Davoli-Ferreira, Bruna Araujo David, Margaret M. Kelly, et al. (+6)
11 [GO] 2023―Apr―14 Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post CD19-CAR-T: an EPICOVIDEHA survey Jaap A. van Doesum, Jon Salmanton-García, Francesco Marchesi, Roberta Di Blasi, Iker Falces-Romero, Alba Cabirta, et al. (+44)
12 [GO] 2023―Apr―10 Clinical Impact of Cryopreservation of Allogeneic Hematopoietic Cell Grafts During the Onset of the COVID-19 Pandemic Steven M Devine, Stephanie Bo-Subait, Michelle Kuxhausen, Stephen R. Spellman, Caitrin Bupp, Kwang Woo Ahn, et al. (+4)
13 [GO] 2023―Apr―06 A Pandemic Preparedness Network for Individuals Living with Compromised Immune Systems William A Wood, Kenneth C. Anderson, Shaji K Kumar, Emily Semmel, Kathleen Hewitt, Robert M Plovnick, Gregory Pappas
14 [GO] 2023―Mar―24 Randomized, Double Blinded, Placebo Controlled Trial of Allogeneic Cord Blood T-Regulatory Cell for Treatment of COVID-19 ARDS Douglas E. Gladstone, Franco R D'Alessio, Christopher Howard, Mi-Ae Lyu, Jason R Mock, Kevin W Gibbs, et al. (+13)
15 [GO] 2023―Mar―22 Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia Robby Engelmann, Nadja Jaekel, Sabrina Jotschke, Beatrice Ludwig-Kraus, Frank Bernhard Kraus, Neha Kumari, et al. (+6)
16 [GO] 2023―Mar―21 Visco C, Marcheselli L, Mina R, et al. A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. Blood Adv. (2022);6(1):327-338.
17 [GO] 2023―Mar―15 Circulating SARS-CoV-2+ Megakaryocytes Associate with Severe Viral Infection in COVID-19 Seth D. Fortmann, Michael Patton, Blake F. Frey, Jennifer L. Tipper, Sivani B. Reddy, Cristiano P. Vieira, et al. (+15)
18 [GO] 2023―Mar―03 Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021;5(20):3951-3959.
19 [GO] 2023―Feb―01 Risk of COVID-19 Infection in Long-term Survivors of Blood or Marrow Transplantation: A BMTSS Report Emily E Johnston, Qingrui Meng, Lindsey Hageman, Jessica Wu, Elizabeth Schlichting Ross, Shawn Lim, et al. (+11)
20 [GO] 2023―Jan―25 Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies Kelly Sharon Chien, Christine Peterson, Elliana Young, Dai Chihara, Elizabet E Manasanch, Jeremy Ramdial, Philip A Thompson
21 [GO] 2023―Jan―11 Analysis of immune responses in CLL patients after heterologous COVID-19 vaccination Hye Kyung Lee, Manuela A. Hoechstetter, Maike Buchner, Trang Thu Pham, Jin Won Huh, Katharina Müller, et al. (+9)
22 [GO] 2023―Jan―09 Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B cell malignancies Andres Chang, Jean L. Koff, Lilin Lai, Victor Manuel Orellana-Noia, Minal Surati, Alyssa Leal, et al. (+11)
23 [GO] 2022―Dec―20 Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis Nipat Chuleerarux, Kasama Manothummetha, Chatphatai Moonla, Anawin Sanguankeo, Olivia S. Kates, Nattiya Hirankarn, et al. (+17)
24 [GO] 2022―Dec―14 Diminished Humoral and Cellular Responses to SARS-CoV-2 Vaccines in Patients with Chronic Lymphocytic Leukemia Chaitra S Ujjani, Ted A Gooley, Stephen E. Spurgeon, Deborah M. Stephens, Catherine Lai, Catherine M. Broome, et al. (+20)
25 [GO] 2022―Nov―18 Transcriptional reprogramming of infiltrating neutrophils drives lung disease in severe COVID-19 despite low viral load Devon J. Eddins, Junkai Yang, Astrid Kosters, Vincent Giacalone, Ximo Pechuan, Joshua D. Chandler, et al. (+13)
26 [GO] 2022―Oct―28 Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination Carla Valsecchi, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Lucia Schiavone, Cristina Novembrino, et al. (+3)
27 [GO] 2022―Oct―19 Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status Nareg H Roubinian, David R Vinson, Tess Wheeler Knudson-Fitzpatrick, Dustin G Mark, Jacek Skarbinski, Catherine Lee, et al. (+2)
28 [GO] 2022―Oct―07 Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR-T cell therapy Hannah Reimann, Anita N Kremer, Viktoria Blumenberg, Katja Gabriele Schmidt, Michael Aigner, Benedikt Jacobs, et al. (+20)
29 [GO] 2022―Sep―26 Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19 Juan G. Ripoll, Ellen K Gorman, Justin E Juskewitch, Raymund R Razonable, Ravindra Ganesh, Ryan T Hurt, et al. (+7)
30 [GO] 2022―Sep―12 Humoral and Cellular Responses to SARS-CoV-2 Vaccines Before and After Chimeric Antigen Receptor-Modified T Cell Therapy Michael A Gonzalez, Atif M Bhatti, Kristin Fitzpatrick, Jim Boonyaratanakornkit, Meei-Li Huang, Victoria L Campbell, et al. (+11)
31 [GO] 2022―Sep―09 Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders Patrick Harrington, Ashwini Kurshan, Marc Delord, Thomas Lechmere, Amna Sheikh, Jamie Saunders, et al. (+13)
32 [GO] 2022―Sep―02 Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as therapeutic target in COVID-19 Lukas Johannes Weiss, Maria Drayss, Georgi Manukjan, Maximilian Josef Zeitlhöefler, Judith Kleiss, Mathis Leonard Weigel, et al. (+12)
33 [GO] 2022―Aug―17 Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents Margo E MacDonald, Rachel K Weathered, Emma C Stewart, Alexandra I. Magold, Anish Mukherjee, Sandeep Gurbuxani, et al. (+14)
34 [GO] 2022―Jul―05 Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19 Cédric Garcia, Jonathan Au Duong, Michael Poëtte, Agnès Ribes, Bruno Payre, Vincent Mémier, et al. (+5)
35 [GO] 2022―Jun―29 Emerging Clinical Trial Designs May Accelerate Translation in Hematology: Lessons from COVID-19 Matthew D Neal, Patrick R Lawler, Ryan Zarychanski
36 [GO] 2022―Jun―27 COVID-19 and venous thromboembolism risk in patients with sickle cell disease Ashima Singh, Amanda M. Brandow, Ted Wun, Arun S. Shet
37 [GO] 2022―Jun―02 Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination Agnes Y. Y. Lee, Muntadhar Al Moosawi, Erica A. Peterson, Rita K. McCracken, Steven K. W. Wong, Hamish Nicolson, et al. (+23)
38 [GO] 2022―May―04 Aiello S, Gastoldi S, Galbusera M, et al. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Blood Adv. 2022;6(3):866-881.
39 [GO] 2022―May―03 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+40)
40 [GO] 2022―May―02 COVID-19 and Hairy-Cell Leukemia: An EPICOVIDEHA Survey Sylvain Lamure, Jon Salmanton-García, Elena ROBIN MARIETON, Ozren Jaksic, Milena Kohn, Francesco Marchesi, et al. (+40)
41 [GO] 2022―Apr―22 SARS-CoV-2 Infection Associated with Aplastic Anemia and Pure Red Cell Aplasia Nicholas C Lee, Bhavisha A Patel, Aaron M. Etra, Taha Bat, Ibrahim F Ibrahim, Madhuri Vusirikala, et al. (+5)
42 [GO] 2022―Apr―20 Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells Florian Puhm, Isabelle Allaeys, Emile Lacasse, Isabelle Dubuc, Yannick Galipeau, Younes Zaid, et al. (+8)
43 [GO] 2022―Apr―20 Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern Maggie Li, Evan J Beck, Oliver Laeyendecker, Yolanda Eby, Aaron AR Tobian, Patrizio Caturegli, et al. (+28)
44 [GO] 2022―Apr―19 Singh A, Brandow AM, Panepinto JA. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv. 2021;5(7):1915-1921.
45 [GO] 2022―Apr―14 Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19 Eugenio Damaceno Hottz, Remy Martins-Gonçalves, Lohanna Palhinha, Isaclaudia G. Azevedo-Quintanilha, Mariana M. de Campos, Carolina Q. Sacramento, et al. (+13)
46 [GO] 2022―Mar―14 Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity Sigrun Einarsdottir, Anna Martner, Jesper Waldenström, Malin Nicklasson, Johan Ringlander, Mohammad Arabpour, et al. (+14)
47 [GO] 2022―Mar―04 Commissioned Commentary on the 2021 American Society of Hematology Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital Alex C. Spyropoulos, Renato D. Lopes
48 [GO] 2022―Mar―02 Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19 Michael W. Henderson, Franciele Lima, Carla Roberta Peachizepi Moraes, Anton Ilich, Stephany Cares Huber, Mayck Silva Barbosa, et al. (+16)
49 [GO] 2022―Feb―03 Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients Sabine Haggenburg, Birgit I. Lissenberg-Witte, Rob S Van BInnendijk, Gerco Den Hartog, Michel S Bhoekhan, Nienke J.E. Haverkate, et al. (+41)
50 [GO] 2022―Feb―02 Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax ANNA CANDONI
51 [GO] 2022―Jan―24 A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses Elena Pettini, Annalisa Ciabattini, Gabiria Pastore, Jacopo Polvere, Simone Lucchesi, Fabio Fiorino, et al. (+5)
52 [GO] 2022―Jan―24 Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study J. Erika Haydu, Jenny S Maron, Robert A Redd, Kathleen M E Gallagher, Stephanie Fischinger, Jeffrey A. Barnes, et al. (+24)
53 [GO] 2022―Jan―10 Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19 Jan Zlamal, Karina Althaus, Hisham Jaffal, Helene Häberle, Lisann Pelzl, Anurag Singh, et al. (+10)
54 [GO] 2022―Jan―10 Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity Hoda Pourhassan, CORINNA LA ROSA, Flavia Chiuppesi, Alfredo Puing, Ibrahim Aldoss, Yoonsuh Park, et al. (+12)
55 [GO] 2022―Jan―10 SARS-CoV-2-specific T-cell responses to recurrent COVID-19 pneumonitis in a patient with post-CART B cell aplasia Angus Hodder, Lindsey Williams, Jan Chu, Alasdair Bamford, Charlene Rodrigues, Kimberley C Gilmour, et al. (+5)
56 [GO] 2022―Jan―06 Inflammasome activation in neutrophils of patients with severe COVID-19 Karen Aymonnier, Julie Ng, Laura E Fredenburgh, Katherin Zambrano-Vera, Patrick Münzer, Sarah Gutch, et al. (+8)
57 [GO] 2021―Dec―24 COVID-19 vaccination in patients with immune thrombocytopenia Chantal Visser, Maurice Swinkels, Erik van Werkhoven, F. Nanne Nanne Croles, Heike Susanne Noordzij-Nooteboom, Matthijs Eefting, et al. (+12)
58 [GO] 2021―Dec―23 Impaired Immune Response to COVID-19 Vaccination in Patients with B-Cell Malignancies after CD19 CART Cell Therapy Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie V. Avila, Thierry Iraguha, Philip J Margiotta, et al. (+10)
59 [GO] 2021―Dec―15 SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma Jakob J Malin, Veronica Di Cristanziano, Carola Horn, Elisabeth Pracht, Jorge Garcia Borrega, Eva Heger, et al. (+10)
60 [GO] 2021―Dec―14 Booster effect after SARS-CoV-2 vaccination in hematological immunocompromised patients with prior COVID-19 Jose Luis L Piñana, Ramon Garcia-Sanz, RODRIGO MARTINO, Maria Garcia-Roa, Gabriel-Andres Martin-Martin, Irene Risco-Galvez, et al. (+11)
61 [GO] 2021―Dec―06 Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia Zoe Lyski, Myung S Kim, David Xthona Lee, Hans-Peter Raué , Vikram Raghunathan, Janet Griffin, et al. (+6)
62 [GO] 2021―Dec―03 Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19 Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, Laura Michalick, Oleg Pak, Astrid-Solveig Schultz, et al. (+19)
63 [GO] 2021―Dec―01 C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19 Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, Piero Luigi Ruggenenti, Valentina Portalupi, Stefano Rota, et al. (+9)
64 [GO] 2021―Dec―01 Immunogenicity of COVID-19 vaccines in patients with hematological malignancy: a systematic review and meta-analysis Joanne S.K. Teh, Julien Coussement, Zoe C.F. Neoh, Tim Spelman, Smaro Lazarakis, Monica A Slavin, Benjamin W Teh
65 [GO] 2021―Nov―29 Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies Moraima Jiménez, Elisa Roldan, Candela Fernández- Naval, Guillermo Villacampa, Monica Martinez-Gallo, Daniel Medina-Gil, et al. (+23)
66 [GO] 2021―Nov―08 COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, Roberta Di Blasi, et al. (+23)
67 [GO] 2021―Nov―02 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+47)
68 [GO] 2021―Nov―01 SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia Jacob Appelbaum, Donald M. Arnold, John G. Kelton, Terry B Gernsheimer, Stefan D Jevtic, Nikola Ivetic, et al. (+2)
69 [GO] 2021―Oct―18 A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study Carlo Visco, Luigi Marcheselli, Roberto Mina, Marianna Sassone, Anna Guidetti, Domenico Penna, et al. (+51)
70 [GO] 2021―Oct―06 Six Months Antibody Persistence after BNT162b2 mRNA COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Shai Levi, Gabi Shefer, Yotam Bronstein, Miguel Morales Moshiashvili, et al. (+4)
71 [GO] 2021―Sep―28 Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection Lauren E. Merz, Kavita Mistry, Donna Neuberg, Revital Freedman, Gerda Menard, David M. Dorfman, et al. (+3)
72 [GO] 2021―Sep―20 Heparin-induced Thrombocytopenia in Patients with Coronavirus Disease 2019: Systematic Review and Meta-analysis Noppacharn Uaprasert, Nuanrat Tangcheewinsirikul, Ponlapat Rojnuckarin, Rushad Patell, Jeffrey I. Zwicker, Thita Chiasakul
73 [GO] 2021―Sep―16 Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2; a prospective study Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+8)
74 [GO] 2021―Sep―02 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+41)
75 [GO] 2021―Aug―13 Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma C. Perry, E. Luttwak, R. Balaban, G. Shefer, M. M. Morales, A. Aharon, et al. (+10)
76 [GO] 2021―Aug―13 Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies Jennifer L. Crombie, Amy C. Sherman, Chi-An Cheng, Christine E. Ryan, Rebecca Zon, Michaël Desjardins, et al. (+13)
77 [GO] 2021―Jul―13 Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
78 [GO] 2021―Jul―01 Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease Lana Mucalo, Amanda M. Brandow, Mahua Dasgupta, Sadie F. Mason, Pippa M. Simpson, Ashima Singh, et al. (+4)
79 [GO] 2021―Jun―17 A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, et al. (+13)
80 [GO] 2021―Apr―01 COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals Ashima Singh, Amanda M. Brandow, Julie A. Panepinto
81 [GO] 2021―Apr―01 Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation Chikara Ogimi, Hu Xie, Alpana Waghmare, Masumi Ueda Oshima, Kanwaldeep K. Mallhi, Keith R. Jerome, et al. (+3)
82 [GO] 2021―Mar―08 Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity Johan Courjon, Océane Dufies, Alexandre Robert, Laurent Bailly, Cédric Torre, David Chirio, et al. (+17)
83 [GO] 2021―Mar―03 The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A Shang-Chuen Wu, Connie M. Arthur, Jianmei Wang, Hans Verkerke, Cassandra D. Josephson, Daniel Kalman, et al. (+3)
84 [GO] 2021―Feb―26 A neutrophil activation signature predicts critical illness and mortality in COVID-19 Matthew L. Meizlish, Alexander B. Pine, Jason D. Bishai, George Goshua, Emily R. Nadelmann, Michael Simonov, et al. (+24)
85 [GO] 2021―Feb―10 Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19 Chaja F. Jacobs, Eric Eldering, Arnon P. Kater
86 [GO] 2021―Feb―09 American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+39)
87 [GO] 2021―Feb―09 COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience Katie Maurer, Anna Saucier, Haesook T. Kim, Utkarsh Acharya, Clifton C. Mo, Julie Porter, et al. (+11)
88 [GO] 2021―Feb―06 Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Maria Magnusson, Nigel Mackman, et al. (+2)
89 [GO] 2021―Feb―02 Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 Erica Villa, Rosina Critelli, Simone Lasagni, Alessandra Melegari, Angela Curatolo, Ciro Celsa, et al. (+28)
90 [GO] 2021―Jan―29 Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19 Christophe Guervilly, Amandine Bonifay, Stephane Burtey, Florence Sabatier, Raphaël Cauchois, Evelyne Abdili, et al. (+10)
91 [GO] 2021―Jan―29 Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19 Younes Zaid, Fadila Guessous, Florian Puhm, Wail Elhamdani, Lamyae Chentoufi, Andrew Conway Morris, et al. (+4)
92 [GO] 2021―Jan―13 Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection Caterina P. Minniti, Ahmar U. Zaidi, Mehdi Nouraie, Deepa Manwani, Gary D. Crouch, Andrew S. Crouch, et al. (+8)
93 [GO] 2020―Dec―18 A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies Deborah M. Siegal, Geoffrey D. Barnes, Nicole J. Langlois, Adrienne Lee, Saskia Middeldorp, Leslie Skeith, et al. (+2)
94 [GO] 2020―Dec―17 Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up Richard Salisbury, Valentina Iotchkova, Sarah Jaafar, Joshua Morton, Gavinda Sangha, Akshay Shah, et al. (+3)
95 [GO] 2020―Dec―09 Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations Caroline Diorio, Kevin O. McNerney, Michele Lambert, Michele Paessler, Elizabeth M. Anderson, Sarah E. Henrickson, et al. (+22)
96 [GO] 2020―Dec―05 Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, J. Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
97 [GO] 2020―Dec―05 Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients Susanne Ghandili, Susanne Pfefferle, Kevin Roedl, Piet Sonnemann, Panagiotis Karagiannis, Olaf Boenisch, et al. (+11)
98 [GO] 2020―Nov―02 Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study Jason B. Hill, David Garcia, Mark Crowther, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
99 [GO] 2020―Oct―19 Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19 Mohammed Osman, Rehan M. Faridi, Wendy Sligl, Meer-Taher Shabani-Rad, Poonam Dharmani-Khan, Arabesque Parker, et al. (+5)
100 [GO] 2020―Oct―14 The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra, Donald E. G. Griesdale, Dana V. Devine, Sophie Stukas, et al. (+8)
101 [GO] 2020―Oct―14 Reduced prevalence of SARS-CoV-2 infection in ABO blood group O Mike Bogetofte Barnkob, Anton Pottegård, Henrik Støvring, Thure Mors Haunstrup, Keld Homburg, Rune Larsen, et al. (+5)
102 [GO] 2020―Oct―08 Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19 Tim Luetkens, Ryan Metcalf, Vicente Planelles, Yue Zheng, Erin T. Larragoite, Emily S. Spivak, et al. (+11)
103 [GO] 2020―Sep―14 Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia Lia Phillips, Jovana Pavisic, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Nobuko Hijiya
104 [GO] 2020―Sep―11 COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease Zahidee Rodriguez, Andi L. Shane, Hans Verkerke, Christopher Lough, Matthew G. Zimmerman, Mehul Suthar, et al. (+8)
105 [GO] 2020―Sep―04 Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic Duncan Purtill, Vicki Antonenas, Paul Chiappini, Daochen Tong, Elizabeth O’Flaherty, Ashish Bajel, et al. (+11)
106 [GO] 2020―Aug―25 The management of venous thromboembolism in hospitalized patients with COVID-19 Alex C. Spyropoulos
107 [GO] 2020―Jul―01 Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) Bruno Fattizzo, Juri Alessandro Giannotta, Wilma Barcellini, Maria Chiara Barbanti, Cristina Bucelli, Ramona Cassin, et al. (+25)
108 [GO] 2020―Jun―23 COVID-19 coagulopathy vs disseminated intravascular coagulation Marcel Levi
109 [GO] 2020―Jun―19 A report of clustered COVID-19 in a hematology ward Yaohui Wu, Fang Liu, Yun Fang, Xuan Lu, Yingying Wu, Linghui Xia, Mei Hong
110 [GO] 2020―Apr―03 First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab Xuhan Zhang, Kaidi Song, Fei Tong, Mingming Fei, Hui Guo, Zhaohui Lu, et al. (+2)

110 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec